Aelis Farma (STU:69O) Total Liabilities: €7.61 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:69O Aelis Farma SA STU:69O
37 GF Score
Price €1.02
GF Value €0.85
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Aelis Farma Total Liabilities?

Aelis Farma STU:69O -1.73% 37 Total Liabilities is €7.61 Mil as of Dec. 2025. GuruFocus rates STU:69O with a GF Score™ of 37/100 and a GF Value™ of €0.85 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Aelis Farma's Total Liabilities for the quarter that ended in Dec. 2025 was €7.61 Mil.

Aelis Farma's quarterly Total Liabilities declined from Dec. 2024 (€9.59 Mil) to Jun. 2025 (€9.47 Mil) and declined from Jun. 2025 (€9.47 Mil) to Dec. 2025 (€7.61 Mil).

Aelis Farma's annual Total Liabilities declined from Dec. 2023 (€13.08 Mil) to Dec. 2024 (€9.59 Mil) and declined from Dec. 2024 (€9.59 Mil) to Dec. 2025 (€7.61 Mil).

Aelis Farma Total Liabilities Historical Data

* Premium members only.

The historical data trend for Aelis Farma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aelis Farma Total Liabilities Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 27.42 19.43 13.08 9.59 7.61

Aelis Farma Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.08 10.53 9.59 9.47 7.61
STU:69O
37GF Score
Aelis Farma SA STU:69O
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aelis Farma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Aelis Farma's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.34+(5.17+-0.00099999999999981
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.1+0)
=7.61

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=12.048-4.439
=7.61

Aelis Farma's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.34+(5.17+-0.00099999999999981
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.1+0)
=7.61

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=12.048-4.439
=7.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €7.61 Mil mean?
Aelis Farma (STU:69O) has a Total Liabilities of €7.61 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Aelis Farma and its competitors.
Is Aelis Farma's Total Liabilities too high?
Aelis Farma's current Total Liabilities is €7.61 Mil. Overall, Aelis Farma has a GF Score™ of 37/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aelis Farma's Total Liabilities compare to VRTX and REGN?
Aelis Farma's Total Liabilities of €7.61 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Aelis Farma and its competitors. Aelis Farma's current Total Liabilities is €7.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aelis Farma stock overvalued right now?
Based on GuruFocus' analysis, Aelis Farma (STU:69O) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.85, compared to a current price of €1.02 — trading 20.5% above its estimated fair value. The current Total Liabilities is €7.61 Mil. Aelis Farma's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Aelis Farma (STU:69O), the current Total Liabilities is €7.61 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aelis Farma (STU:69O) Overvalued in 2026?

Based on GuruFocus' analysis, Aelis Farma stock appears to be overvalued. The current stock price of €1.02 is trading 20.5% above its estimated GF Value™ of €0.85. GuruFocus considers Aelis Farma to be Modestly Overvalued.

Key valuation signals for STU:69O:

  • Total Liabilities: €7.61 Mil
  • GF Value™: €0.85 vs. price of €1.02 (20.5% above fair value)
  • GF Score™: 37/100 with 4 warning signs

No single metric tells the full story. See the STU:69O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aelis Farma Business Description

Other Exchanges AELIS:France69O:Germany
Address 2 rue Robert Escarpit, IECB, Pessac, Bordeaux, FRA, 33607
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases. The Company operates in only one business segment: the research and development of pharmaceutical products.
37GF Score

Get the complete analysis for STU:69O

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.02
Price
€0.85
GF Value